Anzeige
Mehr »
Freitag, 09.01.2026 - Börsentäglich über 12.000 News
Steht diese NASDAQ-Biotech-Aktie jetzt vor einer seltenen Kaufgelegenheit?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
678 Leser
Artikel bewerten:
(0)

Philips Brings New Anesthesia Product and Patient Monitors to Market

ANDOVER, Mass., Oct. 16, 2013 /PRNewswire/ -- Expanding its scope of solutions for anesthesiologists, Royal Philips (NYSE: PHG AEX: PHIA) today launched three new products: IntelliSave AX700 anesthesia machine and, IntelliVue MX400 and MX450 patient monitors. Delivering ease of use, durability and leading-edge innovation, the products were announced at the annual American Society of Anesthesiologists meeting in San Francisco, CA.

The Philips anesthesia product, IntelliSave AX700, which recently received 510(k) clearance, is designed as the centerpiece of the complete anesthesia workstation.

"Patient care today demands quick, reliable and easy to use information at the clinicians' fingertips. Our new technologies include ease of use features, and more importantly, provide doctors with the right information at the right time to make those tough calls," said Mike Mancuso, CEO, Patient Care and Clinical Informatics at Philips Healthcare. "Our goal at Philips is to bring to market innovative technologies that improve patient outcomes and meet the needs of clinicians all around the world. These new solutions do just that and more."

Meeting the needs of anesthesiologists
The Philips anesthesia product, IntelliSave AX700, which recently received 510(k) clearance, is designed to meet the specific demands of anesthesiologists. As the centerpiece of the complete anesthesia workstation solutions from Philips, this product includes support for low-flow and minimal-flow anesthesia, as well as extensive ventilation capabilities, all packed in a slim and ergonomic, modern design.

Additional capabilities - such as advanced ventilation modes like Pressure Regulated Volume Target, or special support for neonatal or heart-lung machine (HLM) scenarios - are also available. The product also offers the option of a built-in Multigas Module to monitor the levels of different gases. The platforms are adjustable to an anesthesiologist's personal needs, and make use of a breathing system which is compact in size, allowing for easy assembly, disassembly and cleaning. The products include built-in features to support patient safety.

The IntelliSave AX700 communicates with Philips IntelliVue patient monitors via IntelliBridge, a single, standards-based point of interoperability. This enables transfer of data from the AX700 to an anesthesia/clinical information system such as Philips IntelliSpace Anesthesia or Hospital Information System (HIS).

Providing quick, high quality and accessible care
Both the MX400 and 450 are up to 10 percent lighter than the previous MP20/30 series, and have a built-in comfort handle that can accommodate shifting center of gravity for enhanced portability. These monitors also share the design of the rest of the IntelliVue MX family, optimized for easy cleaning and disinfection. Their features offer benefits for users across the hospital system:

  • Patients - The monitors allow access to patient information even during in-hospital transport. Patients can get quality care within seconds, no matter where they are in the hospital.
  • Clinicians - User-friendly features allow clinicians to understand information more easily and help improve diagnostic confidence.
  • Administrators - With the ability to access patient information on the hospital intranet even during in-hospital transport, administrators can reduce workflow gaps in their EMRs.
  • CIO/IT - Easier access to EMRs allows hospital IT to satisfy the clinicians' need for ubiquitous access to information.

Visit Philips Healthcare at booth #1605 at the American Society of Anesthesiologists meeting to view these and other innovative technologies from Philips.

Tweet this: If you're at @ASALifeline ANES2013, stop by at @PhilipsHealth booth #1605 to check out our latest innovations!

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2012 sales of EUR 24.8 billion and employs approximately 115,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at www.philips.com/newscenter.

Philips IntelliSave AX700 interoperates with Philips IntelliVue patient monitors via IntelliBridge, a single, standards-based point of interoperability, enabling seamless data transfer to any clinical information system.

The Philips IntelliVue MX400 and 450 have user-friendly interfaces and allow access to patient information even during in-hospital transport.

The Philips IntelliVue MX400 and 450 have user-friendly interfaces and allow access to patient information even during in-hospital transport.

Related Links
Philips Healthcare
Philips Healthcare Anesthesia Solutions
Philips Newsroom

Image with caption: "The Philips anesthesia product, IntelliSave AX700, which recently received 510(k) clearance, is designed as the centerpiece of the complete anesthesia workstation." Image available at: http://photos.prnewswire.com/prnh/20131016/MM98184-a

Image with caption: "Philips IntelliSave AX700 interoperates with Philips IntelliVue patient monitors via IntelliBridge, a single, standards-based point of interoperability, enabling seamless data transfer to any clinical information system." Image available at: http://photos.prnewswire.com/prnh/20131016/MM98184-b

Image with caption: "The Philips IntelliVue MX400 and 450 have user-friendly interfaces and allow access to patient information even during in-hospital transport." Image available at: http://photos.prnewswire.com/prnh/20131016/MM98184-c

Image with caption: "The Philips IntelliVue MX400 and 450 have user-friendly interfaces and allow access to patient information even during in-hospital transport." Image available at: http://photos.prnewswire.com/prnh/20131016/MM98184-d

Contact:
Kathy O'Reilly
Philips
(o) 978-659-2638 (mobile) 978-221-8919
Kathy.oreilly@philips.com
Twitter: @kathyoreilly

Brittany Cusick
OneVoice Connect
(o) 617-986-5833
Brittany_cusick@lpp.com

SOURCERoyal Philips

© 2013 PR Newswire
Renditeturbo 2026 - 5 Aktien mit Potenzial
2025 neigt sich dem Ende zu, ohne klassische Jahresendrallye, aber mit einem DAX, der viele Kritiker Lügen gestraft hat. Über 21 Prozent Kursplus seit Jahresbeginn, stärker als der US-Markt. Wer hätte das noch vor Monaten erwartet?

Genau solche Entwicklungen machen den Reiz der Börse aus. Denn auch 2026 dürfte wieder alles anders kommen als gedacht. Während viele Analysten weiter steigende Kurse erwarten, rückt eine zentrale Frage in den Fokus: Wo entstehen im kommenden Jahr echte Überraschungen, und wie kann man davon profitieren?

Unser aktueller Spezialreport beleuchtet fünf Entwicklungen, mit denen kaum jemand rechnet, die aber enormes Renditepotenzial bergen. Vom Comeback der Ölwerte über unterschätzte Plattform-Aktien bis hin zur möglichen Wachablösung im KI-Sektor: Wer 2026 überdurchschnittlich abschneiden will, muss antizyklisch denken und frühzeitig Position beziehen.

Im kostenlosen Report stellen wir 5 Aktien vor, die 2026 im Zentrum solcher Wendepunkte stehen könnten. Solide bewertet, gut positioniert und mit überraschend starkem Momentum.

Jetzt kostenlos herunterladen! Bevor andere erkennen, wo die Chancen wirklich liegen!

Dieses exklusive PDF ist nur für kurze Zeit verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.